ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.00
1.33%
US Tech 100
18,982.40
-1.17%
S&P 500
5,447.87
-0.31%
US Dollar vs CAD
1.36465
-0.09%
Bitcoin
61,298.04
1.72%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AbCellera Biologics Inc (ABCL)

  7. AbCellera Biologics Inc (ABCL) News

ABCL

AbCellera Biologics (ABCL)

AbCellera Biologics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABCL
DateTimeSourceHeadlineSymbolCompany
06/13/20243:53PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
06/03/20243:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
05/28/20243:05PMBusiness WireAbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024NASDAQ:ABCLAbCellera Biologics Inc
05/07/20243:47PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABCLAbCellera Biologics Inc
05/07/20243:22PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
05/07/20243:05PMBusiness WireAbCellera Reports Q1 2024 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
05/01/20248:00AMBusiness WireAbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech CompaniesNASDAQ:ABCLAbCellera Biologics Inc
04/08/202411:05AMBusiness WireAbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024NASDAQ:ABCLAbCellera Biologics Inc
04/03/20243:05PMBusiness WireAbCellera to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:ABCLAbCellera Biologics Inc
03/19/20243:05PMBusiness WireAbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024NASDAQ:ABCLAbCellera Biologics Inc
03/11/20248:00AMBusiness WireAbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological ConditionsNASDAQ:ABCLAbCellera Biologics Inc
03/05/20243:30PMBusiness WireAbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024NASDAQ:ABCLAbCellera Biologics Inc
02/27/20241:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
02/23/20243:49PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
02/23/20243:30PMBusiness WireAbCellera Announces Resignation of Board MemberNASDAQ:ABCLAbCellera Biologics Inc
02/22/20247:15PMBusiness WireAbCellera to Present at Upcoming Investor Conferences in MarchNASDAQ:ABCLAbCellera Biologics Inc
02/20/20243:49PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ABCLAbCellera Biologics Inc
02/20/20243:27PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
02/20/20243:05PMBusiness WireAbCellera Reports Full Year 2023 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
01/23/20243:05PMBusiness WireAbCellera to Report Full Year 2023 Financial Results on February 20, 2024NASDAQ:ABCLAbCellera Biologics Inc
01/16/20245:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
01/16/20245:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
01/16/20245:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
01/16/20245:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
12/20/20233:05PMBusiness WireAbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024NASDAQ:ABCLAbCellera Biologics Inc
12/19/20235:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
11/28/20234:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
11/27/20233:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
11/16/20233:05PMBusiness WireAbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023NASDAQ:ABCLAbCellera Biologics Inc
11/08/20232:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:ABCL

Your Recent History

UNSW
TITTERETH
Titter
TG
5KBA
Telstra
COIN
XMOETH
TG
7PI
Poste Italiane S.p.a
NASDAQ
WSTME
TG
0Q4
Quinsam Capital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved